Research graph
References from Differences in attitudes towards retinopathy of prematurity screening programs among neonatologists and ophthalmologists in Taiwan. Local targets link to admitted publications; unresolved targets remain external evidence.
Global, regional and national burden of retinopathy of prematurity among childhood and adolescent: a spatiotemporal analysis based on the Global Burden of Disease Study 2019
10.1136/bmjpo-2023-002267 · 2024 · External reference
Causes of childhood blindness in the United States using the IRIS® registry (Intelligent Research in Sight)
10.1016/j.ophtha.2023.04.004 · 2023 · External reference
Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity
10.1056/nejmoa1007374 · 2011 · External reference
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial
10.1016/s0140-6736(19)31344-3 · 2019 · External reference
Real-world visual outcomes of laser and anti-VEGF treatments for retinopathy of prematurity
10.1016/j.ajo.2021.11.015 · 2022 · External reference
Anatomical and visual outcomes in stage 5 retinopathy of prematurity with microincision vitrectomy surgery
10.1097/iae.0000000000002837 · 2021 · External reference
Structural outcome after surgery for stage 5 retinopathy of prematurity based on the new International Classification: Icrop 3: ICROP 3
10.1097/iae.0000000000003541 · 2022 · External reference
10.1542/peds.2018-3061
10.1542/peds.2018-3061 · 2018 · External reference
UK screening and treatment of retinopathy of prematurity updated 2022 guidelines
2023 · External reference
Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening
10.1542/peds.2008-2697 · 2009 · External reference
Development of modified screening criteria for retinopathy of prematurity: primary results from the postnatal growth and retinopathy of prematurity study
10.1001/jamaophthalmol.2018.2753 · 2018 · External reference
Individual risk prediction for sight-threatening retinopathy of prematurity using birth characteristics
10.1001/jamaophthalmol.2019.4502 · 2020 · External reference
A predictive score for retinopathy of prematurity in very low birth weight preterm infants
10.1038/eye.2011.334 · 2012 · External reference
The Colorado-retinopathy of prematurity model (CO-ROP): postnatal weight gain screening algorithm
10.1016/j.jaapos.2015.10.017 · 2016 · External reference
The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model
10.1001/archophthalmol.2012.2524 · 2012 · External reference
Variations in medical practice of retinopathy of prematurity among 8 Asian countries from an international survey
10.1038/s41598-023-42432-3 · 2023 · External reference
Validation of the Postnatal Growth and retinopathy of prematurity screening criteria in a Taiwanese cohort
10.1016/j.ajo.2021.11.007 · 2022 · External reference
Retinopathy of prematurity screening-asking the proper question
10.1001/jamaophthalmol.2023.2782 · 2023 · External reference
Physiologic effects of retinopathy of prematurity screening examinations
10.1097/anc.0b013e318225a332 · 2011 · External reference
Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the Postnatal Growth and ROP (G-ROP) study
10.1038/s41372-020-0605-5 · 2020 · External reference
Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity
10.1001/archopht.124.12.1711 · 2006 · External reference
Retrospective validation of the Postnatal Growth and retinopathy of prematurity (G-ROP) criteria in a Japanese cohort
10.1016/j.ajo.2019.03.027 · 2019 · External reference
Validation of the Postnatal Growth and retinopathy of prematurity screening criteria
10.1001/jamaophthalmol.2019.4517 · 2020 · External reference
Validation of the postnatal growth and retinopathy of prematurity screening criteria: a retrospective Italian analysis
2021 · External reference
Accuracy of the postnatal growth and retinopathy of prematurity screening criteria in predicting prethreshold retinopathy of prematurity in the tertiary hospital, Bangkok, Thailand
10.4103/tjo.tjo-d-23-00027 · 2023 · External reference
Using WINROP as an adjuvant screening tool for retinopathy of prematurity in southern Taiwan
10.1055/s-0034-1376389 · 2015 · External reference
Retinopathy of prematurity: a review of risk factors and their clinical significance
10.1016/j.survophthal.2018.04.002 · 2018 · External reference
Screening tool for early postnatal prediction of retinopathy of prematurity in preterm newborns (STEP-ROP)
10.1159/000464459 · 2017 · External reference
Screening and risk factors for retinopathy of prematurity in a tertiary care hospital in Cairo, Egypt
10.2147/opth.s383493 · 2022 · External reference
Relationship between severe bronchopulmonary dysplasia and severe retinopathy of prematurity in premature newborns
10.1016/j.jaapos.2019.02.008 · 2019 · External reference
External validation of a retinopathy of prematurity screening model using artificial intelligence in 3 low- and middle-income populations
10.1001/jamaophthalmol.2022.2135 · 2022 · External reference
An artificial intelligence system for screening and recommending the treatment modalities for retinopathy of prematurity
10.1097/apo.0000000000000638 · 2023 · External reference
Retinopathy of prematurity treatment: asian perspectives
2020 · External reference
Management of retinopathy of prematurity in the Anti-VEGF era: consensus and recommendations from the taiwan pediatric retina (TPR) group
10.1016/j.ajo.2025.09.050 · 2026 · External reference
How to prevent ROP in preterm infants in Indonesia?
10.1002/hsr2.219 · 2021 · External reference
Operational guidelines for ROP in India: a summary
10.4103/ijo.ijo_1827_19 · 2020 · External reference
Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers
10.1186/s12886-024-03836-5 · 2025 · External reference
